Clinical applications for the excimer laser

Cardiovascular Reviews and Reports

Volumn 20, Issue 6, 1999, Pages 330-335

  Ebersole, Douglas G ^a  

^a Watson Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; CARDIOLOGY; EXCIMER LASER; GUIDE WIRE; HEART MUSCLE REVASCULARIZATION; LASER ANGIOPLASTY; LASER SURGERY; RESTENOSIS; REVIEW; SAPHENOUS VEIN GRAFT; STENT;

EID: 0033013511     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Grundfest WS, Segalowitz J, Laudenslager J, et al. The physical and biological basis for laser angioplasty. In: Litvack F (ed). Coronary Laser Angioplasty. Blackwell. Scientific Publications; 1992.
2. Topaz O. Whose fault is it? Notes on "true" versus "pseudo" laser failure (editorial). Cathet Cardiovasc Diagn. 1995;36:1-4.
3. Bittl JA, Ryan TJ, Keaney JF. Coronary artery perforation during excimer laser coronary angioplasty. J Am Coll Cardiol. 1993;21:1158-1165.
4. Bittl JA. Clinical results with excimer laser coronary angioplasty. Semin Intervent Cardiol 1996;1:129-134.
5. Litvak F, Eigler N, Margolis J, et al. Percutaneous excimer laser coronary angioplasty: Results in the first consecutive 3000 patients. J Am Coll Cardiol. 1994;23:323-330.
6. Deckelbaum LI, Natarajan MK, Bittl JA, et al, for the Percutaneous Excimer Laser Angioplasty (PELCA) Investigators. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: A randomized trial. J Am Coll Cardiol. 1995;26:1264-1269.
7. Appelman YEA, Piek JJ, Strikwerda S, et al. Randomized trial of excimer laser versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet. 1996;347:79-84.
8. Reifart N, Vandormael M, Krajcar M, et al. Randomized comparison of angioplasty of complex coronary lesions at a single center: Excimer laser, Rotational atherectomy, and Balloon Angioplasty Comparison (ERBAC) study. Circulation. 1997;96:91-98
9. Bittl JA, Sanborn TA, Yardley DE, et al. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass lesions. Am J Cardiol. 1994;74:144-148.
10. Wolfe MW, Roubin GS, Schwieger M, et al. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty: Clinical and procedural predictors. Circulation. 1995;92:311-319
11. Holmes DR Jr, Topol EJ, Califf RM, et al. A multicenter randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions: CAVEAT-II Investigators. Circulation. 1995;91:1966-1974.
12. Hong MK, Wong SC, Popma JJ, et al. Favorable results of debulking followed by immediate adjunct stent therapy for high risk saphenous vein graft lesions (abstract). J Am Coll Cardiol. 1996;27:179A.
13. Hong MD, Satler LF, Kent KM, et al. Six-month results of debulking followed by immediate stent therapy for high risk saphenous vein graft lesions (abstract). J Am Coll Cardiol. 1997;29:17A.
14. Tcheng JE, Bittl JA, Sanborn TA, et al. Treatment of aorto-ostial disease with percutaneous excimer laser coronary angioplasty (abstract). Circulation. 1992;86:I512A.
15. Eigler NL, Weinstock B, Douglas JS Jr, et al. Excimer laser coronary angioplasty of aorto-ostial stenoses: Results of the Excimer Laser Coronary Angioplasty (ELCA) registry in the first 200 patients. Circulation. 1993;88:2049-2057.
16. Holmes DR Jr, Forrester JS, Litvack F, et al. Chronic total obstruction and short-term outcome: The excimer laser angioplasty registry experience. Mayo Clin Proc. 1993;68:5-10.
17. Buchwals AB, Werner GS, Unterberg C, et al. Restenosis after excimer laser angioplasty of coronary stenosis and chronic total occlusions. Am Heart J. 1992;123:878-885.
18. Schofer J, Kresser J, Rau T, et al. Recanalization of chronic coronary artery occlusions using laser followed by balloon angioplasty. Am J Cardiol. 1996:78:836-838.
19. Ivanhoe RJ, Weintraub WS, Douglas JS Jr, et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions: Primary success, restenosis and long-term clinical follow-up. Circulation. 1992;85:106-115.
20. Hamberger JN, deFeyter PJ, Serruys PW. The laser guidewire experience: 'Crossing the rubicon.' Semin Intervent Cardiol. 1996;1:163-171.
21. Eltchaninoff H, Koning R, Tron C, et al. Balloon angioplasty for the treatment of coronary in-stent restenosis: Immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998;32:980-984.
22. Yokoi H, Kimura T, Nakagawa Y, et al. Long-term clinical and quantitative angiographic follow-up after the Palmaz-Schatz stent restenosis (abstract). J Am Coll Cardiol. 1996;27:224A.
23. Mehran R, Mintz GS, Popma JJ, et al. Mechanism and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol. 1996;76:618-622.
24. Mehran R, Mints GS, Satler LF, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty: Mechanisms and results compared with PTCA alone. Circulation. 1997;96:2183-2189.
25. Hamm CW, Simon R, Seabra R, et al. Laser angioplasty for within stent restenosis - final results of the LARS surveillance study. J Am Coll Cardiol. 1998;31:143A.
26. Boyd AM. Natural course of arteriosclerosis of lower extremities. Proc R Soc Med. 1962;53:591-595.
27. Imparato AM, Kim Ge, Davidson T, et al. Intermittent claudication: Its natural course. Surgery. 1975;78:795-801.
28. Belli AM, Cumberland DC, Procter AE, et al. Total popliteal artery occlusions: Conventional versus laser thermal recanalization with a hybrid probe in percutaneous angioplasty: Results of a randomized trial. Radiology. 1991;181:57-60.
29. Morgenstern BR, Getrajdman GI, Laffey KJ, et al. Total occlusions of the femoropopliteal artery: High technical success rate of conventional balloon angioplasty. Radiology. 1989;172: 937-940.
30. Stanley B, Teague B, Raptis S, et al. Efficacy of balloon angioplasty of superficial femoral artery and popliteal artery in relief of leg ischemia. J Vasc Surg. 1996;23:79-85.
31. Hunink MGH, Donaldson MC, Myerovitz MF, et al. Risks and benefits of femoropopliteal percutaneous balloon angioplasty. J Vasc Surg. 1993;17:183-194.
32. Dalsing MC, Cockerill E, Deupree R, et al. Outcome predictors in selection of balloon angioplasty or surgery for peripheral arterial occlusive disease. Surgery. 1991;110:636-644
33. Johnston KW. Factors that influence the outcome of aortoiliac and femoropopliteal percutaneous transluminal angioplasty. Endovasc Surg. 1992;72:843-850.
34. Hunink MGM, Wong JB, Donaldson MC, et al. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making. 1994;14:71-81.
35. Byrd C, Wilkhoff B, Love C, et al. Clinical study of the laser sheath: Results of the PLEXES trial (abstract). Pacing Clin Electrophysiol. 1997;20(II):1053.
36. Burkhoff D, Fisher PE, Apfelbaum M, et al. Histologic appearance of transmyocardial laser channels after 41/2 weeks. Ann Thoracic Surg. 1996;61:1532-1535.
37. Gassler N, Wintzer HO, Stubbe HM, et al. Transmyocardial laser revascularization: Histologic features in human nonresponder myocardium. Circulation. 1997;95:371-375.
38. Kohmoto T, Fisher PE, DeRosa C, et al. Evidence of angiogenesis in regions treated with transmyocardial laser revascularization (abstract). Circulation. 1996;94:I-294.
39. Mack CA, Magovern CJ, Hahn RT. Channel patency and neorevascularization following transmyocardial laser revascularization utilizing an excimer laser. Results and comparisons to non-lased channels (abstract). Circulation. 1997;96: 65-69.
40. Pifarre R, Lasuja MI, Lynch RD, et al. Myocardial revascularization by transmyocardial acupuncture: A physiologic impossibility. J Thorac Cardiovasc Surg. 1969;58: 424-431.